Lysine methylation promotes NFAT5 activation and determines temozolomide efficacy in glioblastoma

Temozolomide (TMZ) therapy offers minimal clinical benefits in patients with glioblastoma multiforme (GBM) with high EGFR activity, underscoring the need for effective combination therapy. Here, we show that tonicity-responsive enhancer binding protein (NFAT5) lysine methylation, is a determinant of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yatian, Gao, Zhenyue, Wang, Yuhong, Pang, Bo, Zhang, Binbin, Hu, Ruxin, Wang, Yuqing, Liu, Chao, Zhang, Xuebin, Yang, Jingxuan, Mei, Mei, Wang, Yongzhi, Zhou, Xuan, Li, Min, Ren, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333326/
https://www.ncbi.nlm.nih.gov/pubmed/37429858
http://dx.doi.org/10.1038/s41467-023-39845-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333326/
https://www.ncbi.nlm.nih.gov/pubmed/37429858
http://dx.doi.org/10.1038/s41467-023-39845-z

Ejemplares similares